A multi-centre, phase II, open-label, single arm study of panitumumab, cisplatin and gemcitabine in biliary tract cancer

Primary results of the AGITG TACTIC study

J. Shannon, David Goldstein, Nicole Wong, S Chinchen, Katrin M Sjoquist, Rachel O'Connell, Peter Grimison, Sue-Anne McLachlan, Niall Tebbutt, Lara R. Lipton, Paul Vasey, M. Cronk, S Varma, Michael J Jefford, Eva Segelov, Ehtesham A. Abdi, Siobhan Ng, Chris Karapetis, Val J. Gebski, John Zalcberg

Research output: Contribution to conferencePosterOtherpeer-review

Original languageEnglish
Pages244
Number of pages1
Publication statusPublished - 2014
EventCongress of the European-Cancer-Organization (ECCO) / Multidisciplinary Congress of the European-Society-for-Medical-Oncology (ESMO) -
Duration: 1 Jan 2011 → …

Conference

ConferenceCongress of the European-Cancer-Organization (ECCO) / Multidisciplinary Congress of the European-Society-for-Medical-Oncology (ESMO)
Abbreviated titleECCO
Period1/01/11 → …

Cite this

Shannon, J., Goldstein, D., Wong, N., Chinchen, S., Sjoquist, K. M., O'Connell, R., ... Zalcberg, J. (2014). A multi-centre, phase II, open-label, single arm study of panitumumab, cisplatin and gemcitabine in biliary tract cancer: Primary results of the AGITG TACTIC study. 244. Poster session presented at Congress of the European-Cancer-Organization (ECCO) / Multidisciplinary Congress of the European-Society-for-Medical-Oncology (ESMO), .
Shannon, J. ; Goldstein, David ; Wong, Nicole ; Chinchen, S ; Sjoquist, Katrin M ; O'Connell, Rachel ; Grimison, Peter ; McLachlan, Sue-Anne ; Tebbutt, Niall ; Lipton, Lara R. ; Vasey, Paul ; Cronk, M. ; Varma, S ; Jefford, Michael J ; Segelov, Eva ; Abdi, Ehtesham A. ; Ng, Siobhan ; Karapetis, Chris ; Gebski, Val J. ; Zalcberg, John. / A multi-centre, phase II, open-label, single arm study of panitumumab, cisplatin and gemcitabine in biliary tract cancer : Primary results of the AGITG TACTIC study. Poster session presented at Congress of the European-Cancer-Organization (ECCO) / Multidisciplinary Congress of the European-Society-for-Medical-Oncology (ESMO), .1 p.
@conference{4812119e0acf46e99cdeaf5a5531066d,
title = "A multi-centre, phase II, open-label, single arm study of panitumumab, cisplatin and gemcitabine in biliary tract cancer: Primary results of the AGITG TACTIC study",
author = "J. Shannon and David Goldstein and Nicole Wong and S Chinchen and Sjoquist, {Katrin M} and Rachel O'Connell and Peter Grimison and Sue-Anne McLachlan and Niall Tebbutt and Lipton, {Lara R.} and Paul Vasey and M. Cronk and S Varma and Jefford, {Michael J} and Eva Segelov and Abdi, {Ehtesham A.} and Siobhan Ng and Chris Karapetis and Gebski, {Val J.} and John Zalcberg",
year = "2014",
language = "English",
pages = "244",
note = "Congress of the European-Cancer-Organization (ECCO) / Multidisciplinary Congress of the European-Society-for-Medical-Oncology (ESMO), ECCO ; Conference date: 01-01-2011",

}

Shannon, J, Goldstein, D, Wong, N, Chinchen, S, Sjoquist, KM, O'Connell, R, Grimison, P, McLachlan, S-A, Tebbutt, N, Lipton, LR, Vasey, P, Cronk, M, Varma, S, Jefford, MJ, Segelov, E, Abdi, EA, Ng, S, Karapetis, C, Gebski, VJ & Zalcberg, J 2014, 'A multi-centre, phase II, open-label, single arm study of panitumumab, cisplatin and gemcitabine in biliary tract cancer: Primary results of the AGITG TACTIC study' Congress of the European-Cancer-Organization (ECCO) / Multidisciplinary Congress of the European-Society-for-Medical-Oncology (ESMO), 1/01/11, pp. 244.

A multi-centre, phase II, open-label, single arm study of panitumumab, cisplatin and gemcitabine in biliary tract cancer : Primary results of the AGITG TACTIC study. / Shannon, J.; Goldstein, David ; Wong, Nicole; Chinchen, S; Sjoquist, Katrin M; O'Connell, Rachel; Grimison, Peter; McLachlan, Sue-Anne; Tebbutt, Niall; Lipton, Lara R.; Vasey, Paul; Cronk, M.; Varma, S; Jefford, Michael J; Segelov, Eva; Abdi, Ehtesham A.; Ng, Siobhan; Karapetis, Chris; Gebski, Val J.; Zalcberg, John.

2014. 244 Poster session presented at Congress of the European-Cancer-Organization (ECCO) / Multidisciplinary Congress of the European-Society-for-Medical-Oncology (ESMO), .

Research output: Contribution to conferencePosterOtherpeer-review

TY - CONF

T1 - A multi-centre, phase II, open-label, single arm study of panitumumab, cisplatin and gemcitabine in biliary tract cancer

T2 - Primary results of the AGITG TACTIC study

AU - Shannon, J.

AU - Goldstein, David

AU - Wong, Nicole

AU - Chinchen, S

AU - Sjoquist, Katrin M

AU - O'Connell, Rachel

AU - Grimison, Peter

AU - McLachlan, Sue-Anne

AU - Tebbutt, Niall

AU - Lipton, Lara R.

AU - Vasey, Paul

AU - Cronk, M.

AU - Varma, S

AU - Jefford, Michael J

AU - Segelov, Eva

AU - Abdi, Ehtesham A.

AU - Ng, Siobhan

AU - Karapetis, Chris

AU - Gebski, Val J.

AU - Zalcberg, John

PY - 2014

Y1 - 2014

M3 - Poster

SP - 244

ER -

Shannon J, Goldstein D, Wong N, Chinchen S, Sjoquist KM, O'Connell R et al. A multi-centre, phase II, open-label, single arm study of panitumumab, cisplatin and gemcitabine in biliary tract cancer: Primary results of the AGITG TACTIC study. 2014. Poster session presented at Congress of the European-Cancer-Organization (ECCO) / Multidisciplinary Congress of the European-Society-for-Medical-Oncology (ESMO), .